Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 657M | 625M | 613M | 554M | 567M | 558M |
| Cost of revenue | 403M | 384M | 381M | 347M | 351M | 351M |
| Gross profit | 254M | 241M | 232M | 207M | 216M | 207M |
| Research and development | 30M | 27M | 26M | 26M | 26M | 27M |
| Selling, general and administrative | 99M | 100M | 96M | 88M | 84M | 93M |
| Operating expenses | 153M | 144M | 139M | 137M | 128M | 141M |
| Operating income | 101M | 97M | 93M | 70M | 88M | 66M |
| Pre-tax income | 97M | 95M | 78M | 60M | 78M | 61M |
| Income tax | 22M | 25M | 21M | 16M | 20M | 16M |
| Net income | 75M | 70M | 57M | 44M | 58M | 45M |
| Earnings per share | 3.00 | 2.80 | 2.32 | 1.76 | 2.34 | 1.83 |
| Earnings per share, diluted | 2.96 | 2.77 | 2.30 | 1.75 | 2.32 | 1.82 |
| Weighted average shares | 25M | 25M | 25M | 25M | 25M | 25M |
| Weighted average shares, diluted | 25M | 25M | 25M | 25M | 25M | 25M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 482M | 563M | 815M | 685M | 619M | 725M | 630M | 562M |
| Short-term investments | 279,000 | 287,000 |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 80M | — | — | 66M | — | — |
| Depreciation and amortisation | 19M | 19M | 19M | 18M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 290,000 |
| 298,000 |
| 984,000 |
| 976,000 |
| 1M |
| 971,000 |
| Receivables | 381M | 363M | 374M | 364M | 318M | 294M | 339M | 318M |
| Inventory | 419M | 416M | 397M | 412M | 417M | 416M | 454M | 451M |
| Current assets | 1.38B | 1.44B | 1.67B | 1.54B | 1.43B | 1.55B | 1.56B | 1.46B |
| Property, plant and equipment | 534M | 541M | 514M | 517M | 510M | 477M | 482M | 473M |
| Goodwill | 1.21B | 1.21B | 1.36B | 1.36B | 1.31B | 1.23B | 1.32B | 1.29B |
| Total assets | 3.86B | 3.96B | 4.17B | 4.07B | 3.89B | 3.89B | 4.06B | 3.92B |
| Current liabilities | 527M | 533M | 419M | 380M | 370M | 434M | 440M | 418M |
| Short-term debt | 100M | 96M | 17M | 18M | 18M | 68M | 68M | 68M |
| Long-term debt | 531M | 706M | 789M | 793M | 788M | 789M | 800M | 796M |
| Total liabilities | 1.34B | 1.53B | 1.50B | 1.47B | 1.43B | 1.48B | 1.49B | 1.46B |
| Equity | 2.51B | 2.43B | 2.67B | 2.60B | 2.46B | 2.41B | 2.57B | 2.47B |
| Shares outstanding | — | 27M | 27M | 27M | 27M | 27M | 27M | 27M |
| Shares issued | 27M | 27M | 27M | 27M | 27M | 27M | 27M | 27M |
| Treasury shares | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M |
| 17M |
| 17M |
| Share-based compensation | 6M | — | — | 5M | — | — |
| Capital expenditure | 14M | — | — | 23M | — | — |
| Investing cash flow | −17M | — | — | −81M | — | — |
| Dividends paid | 19M | — | — | 17M | — | — |
| Share buybacks | 0 | — | — | 27M | — | — |
| Financing cash flow | −143M | — | — | −97M | — | — |